{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:49Z","timestamp":1792791469696,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000064","name":"Banting and Best Diabetes Centre, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["24KHRG-1244521"],"award-info":[{"award-number":["24KHRG-1244521"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["38214"],"award-info":[{"award-number":["38214"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24912-w","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:20:27Z","timestamp":1763637627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biphasic actions of the adenosine A2a receptor antagonist istradefylline in mice with obstructive uropathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Emily S. H.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc Tin","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Nagarjun","family":"Batchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren A.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia T.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"24912_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","volume":"113","author":"MR Montinari","year":"2019","unstructured":"Montinari, M. R., Minelli, S. & De Caterina, R. The first 3500 years of aspirin history from its roots\u2014A concise summary. Vascul. Pharmacol. 113, 1\u20138. https:\/\/doi.org\/10.1016\/j.vph.2018.10.008 (2019).","journal-title":"Vascul. Pharmacol."},{"key":"24912_CR2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816 (2020).","journal-title":"N. Engl. J. Med."},{"key":"24912_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker, S. D. et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038 (2021).","journal-title":"N. Engl. J. Med."},{"key":"24912_CR4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/asn.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819\u20131834. https:\/\/doi.org\/10.1681\/asn.2010080793 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24912_CR5","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1111\/bph.16101","volume":"180","author":"H Kaur","year":"2023","unstructured":"Kaur, H. et al. Single cell G-protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21. Br. J. Pharmacol. 180, 2898\u20132915. https:\/\/doi.org\/10.1111\/bph.16101 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"24912_CR6","unstructured":"https:\/\/www.nourianz.com\/assets\/pdf\/nourianz-full-prescribing-information.pdf. Accessed 2nd September 2025."},{"key":"24912_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152924","volume":"132","author":"E Dewaeles","year":"2022","unstructured":"Dewaeles, E. et al. Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects. J. Clin. Invest. 132, e152924. https:\/\/doi.org\/10.1172\/JCI152924 (2022).","journal-title":"J. Clin. Invest."},{"key":"24912_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson, K. A. & Gao, Z. G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247\u2013264. https:\/\/doi.org\/10.1038\/nrd1983 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"24912_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000161","volume":"17","author":"C Xiao","year":"2019","unstructured":"Xiao, C., Liu, N., Jacobson, K. A., Gavrilova, O. & Reitman, M. L. Physiology and effects of nucleosides in mice lacking all four adenosine receptors. PLoS Biol. 17, e3000161. https:\/\/doi.org\/10.1371\/journal.pbio.3000161 (2019).","journal-title":"PLoS Biol."},{"key":"24912_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha, R. A. How does adenosine control neuronal dysfunction and neurodegeneration?. J. Neurochem. 139, 1019\u20131055. https:\/\/doi.org\/10.1111\/jnc.13724 (2016).","journal-title":"J. Neurochem."},{"key":"24912_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.619458","volume":"11","author":"AL Giuliani","year":"2020","unstructured":"Giuliani, A. L., Sarti, A. C. & Di Virgilio, F. Ectonucleotidases in acute and chronic inflammation. Front. Pharmacol. 11, 619458. https:\/\/doi.org\/10.3389\/fphar.2020.619458 (2020).","journal-title":"Front. Pharmacol."},{"key":"24912_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ki.2014.244","volume":"86","author":"VS Roberts","year":"2014","unstructured":"Roberts, V. S., Cowan, P. J., Alexander, S. I., Robson, S. C. & Dwyer, K. M. The role of adenosine receptors A2A and A2B signaling in renal fibrosis. Kidney Int 86, 685\u2013692. https:\/\/doi.org\/10.1038\/ki.2014.244 (2014).","journal-title":"Kidney Int"},{"key":"24912_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI15483","volume":"112","author":"YJ Day","year":"2003","unstructured":"Day, Y. J. et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112, 883\u2013891. https:\/\/doi.org\/10.1172\/JCI15483 (2003).","journal-title":"J. Clin. Invest."},{"key":"24912_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apha.12508","volume":"214","author":"IS Vincent","year":"2015","unstructured":"Vincent, I. S. & Okusa, M. D. Adenosine 2A receptors in acute kidney injury. Acta Physiol (Oxf.) 214, 303\u2013310. https:\/\/doi.org\/10.1111\/apha.12508 (2015).","journal-title":"Acta Physiol (Oxf.)"},{"key":"24912_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.2011.101","volume":"80","author":"GE Garcia","year":"2011","unstructured":"Garcia, G. E., Truong, L. D., Chen, J. F., Johnson, R. J. & Feng, L. Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation. Kidney Int. 80, 378\u2013388. https:\/\/doi.org\/10.1038\/ki.2011.101 (2011).","journal-title":"Kidney Int."},{"key":"24912_CR16","doi-asserted-by":"publisher","first-page":"F828","DOI":"10.1152\/ajprenal.00310.2005","volume":"290","author":"AS Awad","year":"2006","unstructured":"Awad, A. S. et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 290, F828-837. https:\/\/doi.org\/10.1152\/ajprenal.00310.2005 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"24912_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.acthis.2012.09.002","volume":"115","author":"H Xiao","year":"2013","unstructured":"Xiao, H. et al. The effects of adenosine A2A receptor knockout on renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Acta Histochem. 115, 315\u2013319. https:\/\/doi.org\/10.1016\/j.acthis.2012.09.002 (2013).","journal-title":"Acta Histochem."},{"key":"24912_CR18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.7150\/ijbs.92371","volume":"20","author":"S Park","year":"2024","unstructured":"Park, S. et al. A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model. Int. J. Biol. Sci. 20, 1855\u20131870. https:\/\/doi.org\/10.7150\/ijbs.92371 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"24912_CR19","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/art.21974","volume":"54","author":"ES Chan","year":"2006","unstructured":"Chan, E. S. et al. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum. 54, 2632\u20132642. https:\/\/doi.org\/10.1002\/art.21974 (2006).","journal-title":"Arthritis Rheum."},{"key":"24912_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2353\/ajpath.2008.070952","volume":"172","author":"P Fernandez","year":"2008","unstructured":"Fernandez, P. et al. Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am. J. Pathol. 172, 1675\u20131682. https:\/\/doi.org\/10.2353\/ajpath.2008.070952 (2008).","journal-title":"Am. J. Pathol."},{"key":"24912_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10753-008-9078-y","volume":"31","author":"M Katebi","year":"2008","unstructured":"Katebi, M., Fernandez, P., Chan, E. S. & Cronstein, B. N. Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation 31, 299\u2013303. https:\/\/doi.org\/10.1007\/s10753-008-9078-y (2008).","journal-title":"Inflammation"},{"key":"24912_CR22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.ajpath.2017.05.005","volume":"187","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Adenosine A(2a) receptor blockade diminishes wnt\/beta-catenin signaling in a murine model of bleomycin-induced dermal fibrosis. Am. J. Pathol. 187, 1935\u20131944. https:\/\/doi.org\/10.1016\/j.ajpath.2017.05.005 (2017).","journal-title":"Am. J. Pathol."},{"key":"24912_CR23","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/ndt\/gfp041","volume":"24","author":"S Nakav","year":"2009","unstructured":"Nakav, S. et al. Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. Nephrol. Dial Transplant. 24, 2392\u20132399. https:\/\/doi.org\/10.1093\/ndt\/gfp041 (2009).","journal-title":"Nephrol. Dial Transplant."},{"key":"24912_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1189\/jlb.0607359","volume":"83","author":"G Hasko","year":"2008","unstructured":"Hasko, G. & Pacher, P. A2A receptors in inflammation and injury: Lessons learned from transgenic animals. J. Leukoc. Biol. 83, 447\u2013455. https:\/\/doi.org\/10.1189\/jlb.0607359 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"24912_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049991","author":"LYQ Hong","year":"2023","unstructured":"Hong, L. Y. Q. et al. Altered expression, but small contribution, of the histone demethylase KDM6A in obstructive uropathy in mice. Disease Models Mech. https:\/\/doi.org\/10.1242\/dmm.049991 (2023).","journal-title":"Disease Models Mech."},{"key":"24912_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-12-385526-8.00004-7","volume":"61","author":"J Linden","year":"2011","unstructured":"Linden, J. Regulation of leukocyte function by adenosine receptors. Adv. Pharmacol. 61, 95\u2013114. https:\/\/doi.org\/10.1016\/B978-0-12-385526-8.00004-7 (2011).","journal-title":"Adv. Pharmacol."},{"key":"24912_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jphs.2023.03.002","volume":"152","author":"CC Huang","year":"2023","unstructured":"Huang, C. C. et al. Preservation of vascular endothelial glycocalyx and barrier by activation of adenosine A2A receptor (A(2A)R) improved renal dysfunction in cirrhotic rats. J. Pharmacol. Sci. 152, 50\u201360. https:\/\/doi.org\/10.1016\/j.jphs.2023.03.002 (2023).","journal-title":"J. Pharmacol. Sci."},{"key":"24912_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2013.08.018","volume":"52","author":"MK Tan","year":"2013","unstructured":"Tan, M. K., Lim, H. J., Bennett, E. J., Shi, Y. & Harper, J. W. Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover. Mol. Cell 52, 9\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2013.08.018 (2013).","journal-title":"Mol. Cell"},{"key":"24912_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/08820139.2023.2222746","volume":"52","author":"W Ye","year":"2023","unstructured":"Ye, W. et al. Blockade of IL-11 trans-signaling or JAK2\/STAT3 signaling ameliorates the profibrotic effect of IL-11. Immunol. Invest. 52, 703\u2013716. https:\/\/doi.org\/10.1080\/08820139.2023.2222746 (2023).","journal-title":"Immunol. Invest."},{"key":"24912_CR30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.transproceed.2012.01.079","volume":"44","author":"J Lee","year":"2012","unstructured":"Lee, J., Hwang, L. & Ha, H. Adenosine receptors are up-regulated in unilateral ureteral obstructed rat kidneys. Transplant Proc. 44, 1166\u20131168. https:\/\/doi.org\/10.1016\/j.transproceed.2012.01.079 (2012).","journal-title":"Transplant Proc."},{"key":"24912_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118834","volume":"265","author":"S Pandey","year":"2021","unstructured":"Pandey, S. et al. \u201cAdenosine an old player with new possibilities in kidney diseases\u201d: Preclinical evidences and clinical perspectives. Life Sci. 265, 118834. https:\/\/doi.org\/10.1016\/j.lfs.2020.118834 (2021).","journal-title":"Life Sci."},{"key":"24912_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","volume":"21","author":"P Jenner","year":"2021","unstructured":"Jenner, P., Mori, A., Aradi, S. D. & Hauser, R. A. Istradefylline\u2014A first generation adenosine A(2A) antagonist for the treatment of Parkinson\u2019s disease. Expert Rev. Neurother. 21, 317\u2013333. https:\/\/doi.org\/10.1080\/14737175.2021.1880896 (2021).","journal-title":"Expert Rev. Neurother."},{"key":"24912_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1517\/14740338.2015.1014798","volume":"14","author":"T Muller","year":"2015","unstructured":"Muller, T. The safety of istradefylline for the treatment of Parkinson\u2019s disease. Expert Opin. Drug Saf. 14, 769\u2013775. https:\/\/doi.org\/10.1517\/14740338.2015.1014798 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"24912_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/14656566.2023.2201374","volume":"24","author":"T Muller","year":"2023","unstructured":"Muller, T. The role of istradefylline in the Parkinson\u2019s disease armamentarium. Expert Opin. Pharmacother. 24, 863\u2013871. https:\/\/doi.org\/10.1080\/14656566.2023.2201374 (2023).","journal-title":"Expert Opin. Pharmacother."},{"key":"24912_CR35","doi-asserted-by":"publisher","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","volume":"21","author":"JF Chen","year":"2001","unstructured":"Chen, J. F. et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. J. Neurosci. 21, RC143. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-10-j0001.2001 (2001).","journal-title":"J. Neurosci."},{"key":"24912_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2169\/internalmedicine.39.355","volume":"39","author":"S Klahr","year":"2000","unstructured":"Klahr, S. Obstructive nephropathy. Intern Med. 39, 355\u2013361. https:\/\/doi.org\/10.2169\/internalmedicine.39.355 (2000).","journal-title":"Intern Med."},{"key":"24912_CR37","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1152\/physrev.00027.2022","volume":"103","author":"R Norregaard","year":"2023","unstructured":"Norregaard, R., Mutsaers, H. A. M., Frokiaer, J. & Kwon, T. H. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis. Physiol. Rev. 103, 2827\u20132872. https:\/\/doi.org\/10.1152\/physrev.00027.2022 (2023).","journal-title":"Physiol. Rev."},{"key":"24912_CR38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.bjp.0702310","volume":"126","author":"HM Prior","year":"1999","unstructured":"Prior, H. M., Yates, M. S. & Beech, D. J. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery. Br. J. Pharmacol. 126, 494\u2013500. https:\/\/doi.org\/10.1038\/sj.bjp.0702310 (1999).","journal-title":"Br. J. Pharmacol."},{"key":"24912_CR39","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1124\/jpet.105.091017","volume":"315","author":"PB Hansen","year":"2005","unstructured":"Hansen, P. B. et al. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J. Pharmacol. Exp. Ther. 315, 1150\u20131157. https:\/\/doi.org\/10.1124\/jpet.105.091017 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"24912_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2022.06.004","volume":"188","author":"DE Handy","year":"2022","unstructured":"Handy, D. E. & Loscalzo, J. The role of glutathione peroxidase-1 in health and disease. Free Radic. Biol. Med. 188, 146\u2013161. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.004 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"24912_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2016.06.012","volume":"788","author":"CZ Zhu","year":"2016","unstructured":"Zhu, C. Z. et al. A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury. Eur. J. Pharmacol. 788, 1\u201311. https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.012 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"24912_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1096\/fj.07-8430com","volume":"22","author":"GE Garcia","year":"2008","unstructured":"Garcia, G. E. et al. Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. FASEB J. 22, 445\u2013454. https:\/\/doi.org\/10.1096\/fj.07-8430com (2008).","journal-title":"FASEB J."},{"key":"24912_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/apha.12511","volume":"214","author":"P Persson","year":"2015","unstructured":"Persson, P. et al. Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress. Acta Physiol. (Oxf.) 214, 311\u2013318. https:\/\/doi.org\/10.1111\/apha.12511 (2015).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"24912_CR44","doi-asserted-by":"publisher","first-page":"F107","DOI":"10.1152\/ajprenal.00385.2018","volume":"317","author":"W Cao","year":"2019","unstructured":"Cao, W. et al. Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity. Am. J. Physiol. Renal. Physiol. 317, F107\u2013F115. https:\/\/doi.org\/10.1152\/ajprenal.00385.2018 (2019).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"24912_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer, S. et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature 552, 110\u2013115. https:\/\/doi.org\/10.1038\/nature24676 (2017).","journal-title":"Nature"},{"key":"24912_CR46","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1021\/acs.jmedchem.4c03185","volume":"68","author":"N Pang","year":"2025","unstructured":"Pang, N. et al. Development of a long-acting interleukin-11 antagonist for the treatment of renal fibrosis. J. Med. Chem. 68, 8429\u20138438. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c03185 (2025).","journal-title":"J. Med. Chem."},{"key":"24912_CR47","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1074\/jbc.M113.455675","volume":"288","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Protein kinase A modulates transforming growth factor-beta signaling through a direct interaction with Smad4 protein. J. Biol. Chem. 288, 8737\u20138749. https:\/\/doi.org\/10.1074\/jbc.M113.455675 (2013).","journal-title":"J. Biol. Chem."},{"key":"24912_CR48","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.1074\/jbc.273.14.8522","volume":"273","author":"L Wang","year":"1998","unstructured":"Wang, L., Zhu, Y. & Sharma, K. Transforming growth factor-beta1 stimulates protein kinase A in mesangial cells. J. Biol. Chem. 273, 8522\u20138527. https:\/\/doi.org\/10.1074\/jbc.273.14.8522 (1998).","journal-title":"J. Biol. Chem."},{"key":"24912_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.737426","volume":"9","author":"CM Sorenson","year":"2021","unstructured":"Sorenson, C. M. et al. Caffeine inhibits choroidal neovascularization through mitigation of inflammatory and angiogenesis activities. Front Cell Dev. Biol. 9, 737426. https:\/\/doi.org\/10.3389\/fcell.2021.737426 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"24912_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuropharm.2017.02.021","volume":"117","author":"FM Mouro","year":"2017","unstructured":"Mouro, F. M. et al. Chronic and acute adenosine A(2A) receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB(1) receptor activation. Neuropharmacology 117, 316\u2013327. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.021 (2017).","journal-title":"Neuropharmacology"},{"key":"24912_CR51","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1681\/ASN.2010080890","volume":"22","author":"Y Dai","year":"2011","unstructured":"Dai, Y. et al. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J. Am. Soc. Nephrol. 22, 890\u2013901. https:\/\/doi.org\/10.1681\/ASN.2010080890 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24912_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069114","volume":"8","author":"DJ Chiang","year":"2013","unstructured":"Chiang, D. J. et al. Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis. PLoS ONE 8, e69114. https:\/\/doi.org\/10.1371\/journal.pone.0069114 (2013).","journal-title":"PLoS ONE"},{"key":"24912_CR53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/db20-0765","volume":"70","author":"SN Batchu","year":"2021","unstructured":"Batchu, S. N. et al. Lung and kidney ACE2 and TMPRSS2 in renin-angiotensin system blocker-treated comorbid diabetic mice mimicking host factors that have been linked to severe COVID-19. Diabetes 70, 759\u2013771. https:\/\/doi.org\/10.2337\/db20-0765 (2021).","journal-title":"Diabetes"},{"key":"24912_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2017.10.014","volume":"110","author":"AG Orr","year":"2018","unstructured":"Orr, A. G. et al. Istradefylline reduces memory deficits in aging mice with amyloid pathology. Neurobiol. Dis. 110, 29\u201336. https:\/\/doi.org\/10.1016\/j.nbd.2017.10.014 (2018).","journal-title":"Neurobiol. Dis."},{"key":"24912_CR55","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.3390\/ijms21165756","volume":"21","author":"SN Batchu","year":"2020","unstructured":"Batchu, S. N. et al. The dipeptidyl peptidase-4 inhibitor linagliptin directly enhances the contractile recovery of mouse hearts at a concentration equivalent to that achieved with standard dosing in humans. Int. J. Mol. Sci. 21, 5756. https:\/\/doi.org\/10.3390\/ijms21165756 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"24912_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: A fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360. https:\/\/doi.org\/10.1038\/nmeth.3317 (2015).","journal-title":"Nat. Methods"},{"key":"24912_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122 (2015).","journal-title":"Nat. Biotechnol."},{"key":"24912_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nbt.3172","volume":"33","author":"AC Frazee","year":"2015","unstructured":"Frazee, A. C. et al. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat. Biotechnol. 33, 243\u2013246. https:\/\/doi.org\/10.1038\/nbt.3172 (2015).","journal-title":"Nat. Biotechnol."},{"key":"24912_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161453","volume":"133","author":"VG Yerra","year":"2023","unstructured":"Yerra, V. G. et al. Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure. J. Clin. Invest. 133, e161453. https:\/\/doi.org\/10.1172\/JCI161453 (2023).","journal-title":"J. Clin. Invest."},{"key":"24912_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100246","volume":"2","author":"G Toda","year":"2021","unstructured":"Toda, G., Yamauchi, T., Kadowaki, T. & Ueki, K. Preparation and culture of bone marrow-derived macrophages from mice for functional analysis. STAR Protoc. 2, 100246. https:\/\/doi.org\/10.1016\/j.xpro.2020.100246 (2021).","journal-title":"STAR Protoc."},{"key":"24912_CR61","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00125-019-4967-1","volume":"62","author":"S Majumder","year":"2019","unstructured":"Majumder, S. et al. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease. Diabetologia 62, 2129\u20132142. https:\/\/doi.org\/10.1007\/s00125-019-4967-1 (2019).","journal-title":"Diabetologia"},{"key":"24912_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope: A novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22\u201329. https:\/\/doi.org\/10.1016\/j.jmoldx.2011.08.002 (2012).","journal-title":"J. Mol. Diagn."},{"key":"24912_CR63","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1681\/ASN.2014090898","volume":"27","author":"FS Siddiqi","year":"2016","unstructured":"Siddiqi, F. S. et al. The histone methyltransferase enzyme enhancer of zeste homolog 2 protects against podocyte oxidative stress and renal injury in diabetes. J. Am. Soc. Nephrol. 27, 2021\u20132034. https:\/\/doi.org\/10.1681\/ASN.2014090898 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24912_CR64","doi-asserted-by":"publisher","first-page":"14824","DOI":"10.1074\/jbc.M113.451336","volume":"288","author":"AC Midgley","year":"2013","unstructured":"Midgley, A. C. et al. Transforming growth factor-beta1 (TGF-beta1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J. Biol. Chem. 288, 14824\u201314838. https:\/\/doi.org\/10.1074\/jbc.M113.451336 (2013).","journal-title":"J. Biol. Chem."},{"key":"24912_CR65","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/ijms24021784","volume":"24","author":"M Scuruchi","year":"2023","unstructured":"Scuruchi, M. et al. Biglycan involvement in heart fibrosis: modulation of adenosine 2A receptor improves damage in immortalized cardiac fibroblasts. Int. J. Mol. Sci. 24, 1784. https:\/\/doi.org\/10.3390\/ijms24021784 (2023).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24912-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:20:29Z","timestamp":1763637629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24912-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24912"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24912-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.A. has received research support through his institution from Boehringer Ingelheim. D.A.Y. is a scientific cofounder and consultant for Fibrocor Therapeutics. Other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41110"}}